Growing community of inventors

Heudreville sue eure, France

Mikaël Paugam

Average Co-Inventor Count = 4.74

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 14

Mikaël PaugamJerôme Emile Georges Guillemont (7 patents)Mikaël PaugamJan Heeres (5 patents)Mikaël PaugamPaul Adriaan Jan Janssen (5 patents)Mikaël PaugamPaulus Joannes Lewi (5 patents)Mikaël PaugamBruno Francois Marie Delest (5 patents)Mikaël PaugamBruno François Marie Delest (2 patents)Mikaël PaugamFrank Xavier Jozef Herwig Arts, Legal Representative (1 patent)Mikaël PaugamPaul Adriaan Jan Janssen (0 patent)Mikaël PaugamMikaël Paugam (7 patents)Jerôme Emile Georges GuillemontJerôme Emile Georges Guillemont (27 patents)Jan HeeresJan Heeres (124 patents)Paul Adriaan Jan JanssenPaul Adriaan Jan Janssen (35 patents)Paulus Joannes LewiPaulus Joannes Lewi (25 patents)Bruno Francois Marie DelestBruno Francois Marie Delest (5 patents)Bruno François Marie DelestBruno François Marie Delest (2 patents)Frank Xavier Jozef Herwig Arts, Legal RepresentativeFrank Xavier Jozef Herwig Arts, Legal Representative (5 patents)Paul Adriaan Jan JanssenPaul Adriaan Jan Janssen (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Janssen Sciences Ireland Uc (5 from 111 patents)

2. Tibotec Pharmaceuticals Ltd. (1 from 66 patents)

3. Janssen R&d Ireland (1 from 45 patents)


7 patents:

1. 10077270 - HIV inhibiting bicyclic pyrimidine derivatives

2. 10072015 - HIV inhibiting bicyclic pyrimidine derivatives

3. 9802943 - HIV inhibiting bicyclic pyrimidine derivatives

4. 9573942 - HIV inhibiting 5-amido substituted pyrimidines

5. 9487518 - HIV inhibiting bicyclic pyrimidine derivatives

6. 8933089 - HIV inhibiting 5-amido substituted pyrimidines

7. 8153640 - HIV inhibiting bicyclic pyrimdine derivatives

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…